Arkadiusz K.
- Country
- Poland
- Department
- Deparment of Diabetoloy
Research Overview
- Evaluation of the Safety and Efficacy of Topical Bacteriophage Therapy TP-102 in Diabetic Foot Ulcers Infected by Acinetobacter baumannii, Pseudomonas aeruginosa, or Staphylococcus aureus
- Evaluation of the Efficacy and Safety of 5% EscharEx (Concentrate of Proteolytic Enzymes Enriched in Bromelain) in Debridement of Venous Leg Ulcers
- A phase-2, multi-centre, prospective, randomized, standard-of-care plus placebo-controlled, patient and central evaluator blinded, parallel arm, clinical study to evaluate safety, tolerability and efficacy of the recommended phase-2 dose of AUP1602-C in two dosing frequencies as a topical treatment for non-healing neuro-ischemic diabetic foot ulcers
Data & Insights
Has run more than one trial at 3 of 35 partner sites.
Specializations
Diabetic Complications
This investigator specializes in the treatment of diabetic foot ulcers, with particular emphasis on addressing neuro-ischemic complications in diabetic patients.
- Non-healing wound management
- Diabetic wound care
- Ischemic tissue treatment
The research focus encompasses innovative topical treatments for chronic diabetic wounds.
Wound Care Management
The investigator's expertise centers on advanced wound healing therapies and the evaluation of novel treatment approaches for complex wounds.
- Total wound closure techniques
- Topical therapeutic applications
- Wound healing assessment
Areas of interest include systematic evaluation of wound healing progression and treatment efficacy.
Clinical Therapeutics
The investigator focuses on therapeutic innovations in the field of chronic wound management, with emphasis on safety and tolerability assessments.
- Treatment optimization
- Dosing frequency evaluation
- Clinical safety assessment
Special attention is given to developing standardized approaches for wound treatment protocols.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.